ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

GOVX GeoVax Labs Inc

1.51
0.00 (0.00%)
Pre Market
Last Updated: 11:25:03
Delayed by 15 minutes
Share Name Share Symbol Market Type
GeoVax Labs Inc NASDAQ:GOVX NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 1.51 1.54 1.60 9,476 11:25:03

GeoVax to Present at the Noble Capital Markets Twentieth Annual Emerging Growth Equity Conference

26/11/2024 2:00pm

GlobeNewswire Inc.


GeoVax Labs (NASDAQ:GOVX)
Historical Stock Chart


From Sep 2024 to Mar 2025

Click Here for more GeoVax Labs Charts.

GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company specializing in developing human vaccines and cancer immunotherapies, today announced that its Chairman & CEO, David Dodd, will present at NobleCon20 - the Noble Capital Markets Twentieth Annual Emerging Growth Equity Conference taking place December 2-5, 2024 in Boca Raton, FL.

Presentation Details:
Speaker: David Dodd, Chairman & CEO 
Date/Time: December 3, 2024, 11:30 am ET 
Location: Florida Atlantic University Executive Education Complex, Boca Raton, FL 
Title: GeoVax Corporate Update 

A high-definition video webcast of the presentation will be available the following day on the Company's website www.geovax.com, and as part of a complete catalog of presentations available at Noble Capital Markets’ Conference website: www.nobleconference.com and on Channelchek: www.channelchek.com the investor portal created by Noble. The webcast will be archived on the company's website, the NobleCon website, and on Channelchek.com for 90 days following the event. Senior GeoVax management will also host one-on-one meetings with registered attendees.

About GeoVax

GeoVax Labs, Inc. is a clinical-stage biotechnology company developing novel vaccines for many of the world’s most threatening infectious diseases and therapies for solid tumor cancers. The company’s lead clinical program is GEO-CM04S1, a next-generation COVID-19 vaccine for which GeoVax was recently awarded a BARDA-funded contract to sponsor a 10,000-participant Phase 2b clinical trial to evaluate the efficacy of GEO-CM04S1 versus an approved COVID-19 vaccine. In addition, GEO-CM04S1 is currently in three Phase 2 clinical trials, being evaluated as (1) a primary vaccine for immunocompromised patients such as those suffering from hematologic cancers and other patient populations for whom the current authorized COVID-19 vaccines are insufficient, (2) a booster vaccine in patients with chronic lymphocytic leukemia (CLL) and (3) a more robust, durable COVID-19 booster among healthy patients who previously received the mRNA vaccines. In oncology the lead clinical program is evaluating a novel oncolytic solid tumor gene-directed therapy, Gedeptin®, having recently completed a multicenter Phase 1/2 clinical trial for advanced head and neck cancers. A Phase 2 clinical trial in first recurrent head and neck cancer, evaluating Gedeptin® combined with an immune checkpoint inhibitor is planned to initiate during the first half of 2025. GeoVax has a strong IP portfolio in support of its technologies and product candidates, holding worldwide rights for its technologies and products. The Company has a leadership team who have driven significant value creation across multiple life science companies over the past several decades. For more information about the current status of our clinical trials and other updates, visit our website: www.geovax.com.

Company Contact: Investor Relations Contact: Media Contact:
info@geovax.com austin.murtagh@precisionaq.com sr@roberts-communications.com
678-384-7220 212-698-8696 202-779-0929

1 Year GeoVax Labs Chart

1 Year GeoVax Labs Chart

1 Month GeoVax Labs Chart

1 Month GeoVax Labs Chart

Your Recent History

Delayed Upgrade Clock